Global Molecular Diagnostics Infectious Disease Testing Market Growth (Status and Outlook) 2022-2028
- LP 4947590
- 102 Pages
- April 2022
- Medical Devices
The United States Molecular Diagnostics Infectious Disease Testing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Molecular Diagnostics Infectious Disease Testing market, reaching US$ million by the year 2028. As for the Europe Molecular Diagnostics Infectious Disease Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Molecular Diagnostics Infectious Disease Testing players cover Abbott Laboratories, BD, bioMérieux, and Thermo Fisher Scientific, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnostics Infectious Disease Testing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Bacterial Infectious Disease Testing
Viral Infectious Disease Testing
Parasitic Infectious Disease Testing
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Laboratory Research
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
BD
bioMérieux
Thermo Fisher Scientific
F. Hoffmann-La Roche
Siemens AG
Veridex
Luminex
GenMark Diagnostics
Qiagen NV
Genomix Biotech
BioTheranostics
GenMark Diagnostics
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Molecular Diagnostics Infectious Disease Testing Market Size 2017-2028
2.1.2 Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Molecular Diagnostics Infectious Disease Testing Segment by Type
2.2.1 Bacterial Infectious Disease Testing
2.2.2 Viral Infectious Disease Testing
2.2.3 Parasitic Infectious Disease Testing
2.3 Molecular Diagnostics Infectious Disease Testing Market Size by Type
2.3.1 Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2017-2022)
2.4 Molecular Diagnostics Infectious Disease Testing Segment by Application
2.4.1 Hospital
2.4.2 Laboratory Research
2.5 Molecular Diagnostics Infectious Disease Testing Market Size by Application
2.5.1 Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2017-2022)
3 Molecular Diagnostics Infectious Disease Testing Market Size by Player
3.1 Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Players
3.1.1 Global Molecular Diagnostics Infectious Disease Testing Revenue by Players (2020-2022)
3.1.2 Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Players (2020-2022)
3.2 Global Molecular Diagnostics Infectious Disease Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Molecular Diagnostics Infectious Disease Testing by Regions
4.1 Molecular Diagnostics Infectious Disease Testing Market Size by Regions (2017-2022)
4.2 Americas Molecular Diagnostics Infectious Disease Testing Market Size Growth (2017-2022)
4.3 APAC Molecular Diagnostics Infectious Disease Testing Market Size Growth (2017-2022)
4.4 Europe Molecular Diagnostics Infectious Disease Testing Market Size Growth (2017-2022)
4.5 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Growth (2017-2022)
5 Americas
5.1 Americas Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
5.2 Americas Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022)
5.3 Americas Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostics Infectious Disease Testing Market Size by Region (2017-2022)
6.2 APAC Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022)
6.3 APAC Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Molecular Diagnostics Infectious Disease Testing by Country (2017-2022)
7.2 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022)
7.3 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Molecular Diagnostics Infectious Disease Testing by Region (2017-2022)
8.2 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022)
8.3 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Molecular Diagnostics Infectious Disease Testing Market Forecast
10.1 Global Molecular Diagnostics Infectious Disease Testing Forecast by Regions (2023-2028)
10.1.1 Global Molecular Diagnostics Infectious Disease Testing Forecast by Regions (2023-2028)
10.1.2 Americas Molecular Diagnostics Infectious Disease Testing Forecast
10.1.3 APAC Molecular Diagnostics Infectious Disease Testing Forecast
10.1.4 Europe Molecular Diagnostics Infectious Disease Testing Forecast
10.1.5 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Forecast
10.2 Americas Molecular Diagnostics Infectious Disease Testing Forecast by Country (2023-2028)
10.2.1 United States Molecular Diagnostics Infectious Disease Testing Market Forecast
10.2.2 Canada Molecular Diagnostics Infectious Disease Testing Market Forecast
10.2.3 Mexico Molecular Diagnostics Infectious Disease Testing Market Forecast
10.2.4 Brazil Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3 APAC Molecular Diagnostics Infectious Disease Testing Forecast by Region (2023-2028)
10.3.1 China Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3.2 Japan Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3.3 Korea Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3.4 Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3.5 India Molecular Diagnostics Infectious Disease Testing Market Forecast
10.3.6 Australia Molecular Diagnostics Infectious Disease Testing Market Forecast
10.4 Europe Molecular Diagnostics Infectious Disease Testing Forecast by Country (2023-2028)
10.4.1 Germany Molecular Diagnostics Infectious Disease Testing Market Forecast
10.4.2 France Molecular Diagnostics Infectious Disease Testing Market Forecast
10.4.3 UK Molecular Diagnostics Infectious Disease Testing Market Forecast
10.4.4 Italy Molecular Diagnostics Infectious Disease Testing Market Forecast
10.4.5 Russia Molecular Diagnostics Infectious Disease Testing Market Forecast
10.5 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Forecast by Region (2023-2028)
10.5.1 Egypt Molecular Diagnostics Infectious Disease Testing Market Forecast
10.5.2 South Africa Molecular Diagnostics Infectious Disease Testing Market Forecast
10.5.3 Israel Molecular Diagnostics Infectious Disease Testing Market Forecast
10.5.4 Turkey Molecular Diagnostics Infectious Disease Testing Market Forecast
10.5.5 GCC Countries Molecular Diagnostics Infectious Disease Testing Market Forecast
10.6 Global Molecular Diagnostics Infectious Disease Testing Forecast by Type (2023-2028)
10.7 Global Molecular Diagnostics Infectious Disease Testing Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product Offered
11.1.3 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 BD
11.2.1 BD Company Information
11.2.2 BD Molecular Diagnostics Infectious Disease Testing Product Offered
11.2.3 BD Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 BD Main Business Overview
11.2.5 BD Latest Developments
11.3 bioMérieux
11.3.1 bioMérieux Company Information
11.3.2 bioMérieux Molecular Diagnostics Infectious Disease Testing Product Offered
11.3.3 bioMérieux Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 bioMérieux Main Business Overview
11.3.5 bioMérieux Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product Offered
11.4.3 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Information
11.5.2 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product Offered
11.5.3 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 F. Hoffmann-La Roche Main Business Overview
11.5.5 F. Hoffmann-La Roche Latest Developments
11.6 Siemens AG
11.6.1 Siemens AG Company Information
11.6.2 Siemens AG Molecular Diagnostics Infectious Disease Testing Product Offered
11.6.3 Siemens AG Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Siemens AG Main Business Overview
11.6.5 Siemens AG Latest Developments
11.7 Veridex
11.7.1 Veridex Company Information
11.7.2 Veridex Molecular Diagnostics Infectious Disease Testing Product Offered
11.7.3 Veridex Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Veridex Main Business Overview
11.7.5 Veridex Latest Developments
11.8 Luminex
11.8.1 Luminex Company Information
11.8.2 Luminex Molecular Diagnostics Infectious Disease Testing Product Offered
11.8.3 Luminex Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Luminex Main Business Overview
11.8.5 Luminex Latest Developments
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Information
11.9.2 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Offered
11.9.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 GenMark Diagnostics Main Business Overview
11.9.5 GenMark Diagnostics Latest Developments
11.10 Qiagen NV
11.10.1 Qiagen NV Company Information
11.10.2 Qiagen NV Molecular Diagnostics Infectious Disease Testing Product Offered
11.10.3 Qiagen NV Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Qiagen NV Main Business Overview
11.10.5 Qiagen NV Latest Developments
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Information
11.11.2 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Product Offered
11.11.3 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Genomix Biotech Main Business Overview
11.11.5 Genomix Biotech Latest Developments
11.12 BioTheranostics
11.12.1 BioTheranostics Company Information
11.12.2 BioTheranostics Molecular Diagnostics Infectious Disease Testing Product Offered
11.12.3 BioTheranostics Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 BioTheranostics Main Business Overview
11.12.5 BioTheranostics Latest Developments
11.13 GenMark Diagnostics
11.13.1 GenMark Diagnostics Company Information
11.13.2 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Offered
11.13.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 GenMark Diagnostics Main Business Overview
11.13.5 GenMark Diagnostics Latest Developments
12 Research Findings and Conclusion
Table 1. Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Bacterial Infectious Disease Testing
Table 3. Major Players of Viral Infectious Disease Testing
Table 4. Major Players of Parasitic Infectious Disease Testing
Table 5. Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2017-2022)
Table 8. Molecular Diagnostics Infectious Disease Testing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2017-2022)
Table 11. Global Molecular Diagnostics Infectious Disease Testing Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Player (2020-2022)
Table 13. Molecular Diagnostics Infectious Disease Testing Key Players Head office and Products Offered
Table 14. Molecular Diagnostics Infectious Disease Testing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Molecular Diagnostics Infectious Disease Testing Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Regions (2017-2022)
Table 19. Americas Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Country (2017-2022)
Table 21. Americas Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2017-2022)
Table 23. Americas Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2017-2022)
Table 25. APAC Molecular Diagnostics Infectious Disease Testing Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Region (2017-2022)
Table 27. APAC Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2017-2022)
Table 29. APAC Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2017-2022)
Table 31. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Country (2017-2022)
Table 33. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2017-2022)
Table 35. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Molecular Diagnostics Infectious Disease Testing
Table 44. Key Market Challenges & Risks of Molecular Diagnostics Infectious Disease Testing
Table 45. Key Industry Trends of Molecular Diagnostics Infectious Disease Testing
Table 46. Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share Forecast by Application (2023-2028)
Table 52. Abbott Laboratories Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 53. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product Offered
Table 54. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Abbott Laboratories Main Business
Table 56. Abbott Laboratories Latest Developments
Table 57. BD Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 58. BD Molecular Diagnostics Infectious Disease Testing Product Offered
Table 59. BD Main Business
Table 60. BD Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. BD Latest Developments
Table 62. bioMérieux Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 63. bioMérieux Molecular Diagnostics Infectious Disease Testing Product Offered
Table 64. bioMérieux Main Business
Table 65. bioMérieux Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. bioMérieux Latest Developments
Table 67. Thermo Fisher Scientific Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 68. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product Offered
Table 69. Thermo Fisher Scientific Main Business
Table 70. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Thermo Fisher Scientific Latest Developments
Table 72. F. Hoffmann-La Roche Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 73. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product Offered
Table 74. F. Hoffmann-La Roche Main Business
Table 75. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. F. Hoffmann-La Roche Latest Developments
Table 77. Siemens AG Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 78. Siemens AG Molecular Diagnostics Infectious Disease Testing Product Offered
Table 79. Siemens AG Main Business
Table 80. Siemens AG Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Siemens AG Latest Developments
Table 82. Veridex Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 83. Veridex Molecular Diagnostics Infectious Disease Testing Product Offered
Table 84. Veridex Main Business
Table 85. Veridex Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Veridex Latest Developments
Table 87. Luminex Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 88. Luminex Molecular Diagnostics Infectious Disease Testing Product Offered
Table 89. Luminex Main Business
Table 90. Luminex Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Luminex Latest Developments
Table 92. GenMark Diagnostics Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 93. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Offered
Table 94. GenMark Diagnostics Main Business
Table 95. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. GenMark Diagnostics Latest Developments
Table 97. Qiagen NV Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 98. Qiagen NV Molecular Diagnostics Infectious Disease Testing Product Offered
Table 99. Qiagen NV Main Business
Table 100. Qiagen NV Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Qiagen NV Latest Developments
Table 102. Genomix Biotech Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 103. Genomix Biotech Molecular Diagnostics Infectious Disease Testing Product Offered
Table 104. Genomix Biotech Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Genomix Biotech Main Business
Table 106. Genomix Biotech Latest Developments
Table 107. BioTheranostics Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 108. BioTheranostics Molecular Diagnostics Infectious Disease Testing Product Offered
Table 109. BioTheranostics Main Business
Table 110. BioTheranostics Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. BioTheranostics Latest Developments
Table 112. GenMark Diagnostics Details, Company Type, Molecular Diagnostics Infectious Disease Testing Area Served and Its Competitors
Table 113. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Offered
Table 114. GenMark Diagnostics Main Business
Table 115. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. GenMark Diagnostics Latest Developments
List of Figures
Figure 1. Molecular Diagnostics Infectious Disease Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type in 2021
Figure 7. Molecular Diagnostics Infectious Disease Testing in Hospital
Figure 8. Global Molecular Diagnostics Infectious Disease Testing Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Molecular Diagnostics Infectious Disease Testing in Laboratory Research
Figure 10. Global Molecular Diagnostics Infectious Disease Testing Market: Laboratory Research (2017-2022) & ($ Millions)
Figure 11. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application in 2021
Figure 12. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Player in 2021
Figure 13. Global Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Molecular Diagnostics Infectious Disease Testing Market Size 2017-2022 ($ Millions)
Figure 15. APAC Molecular Diagnostics Infectious Disease Testing Market Size 2017-2022 ($ Millions)
Figure 16. Europe Molecular Diagnostics Infectious Disease Testing Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size 2017-2022 ($ Millions)
Figure 18. Americas Molecular Diagnostics Infectious Disease Testing Value Market Share by Country in 2021
Figure 19. Americas Molecular Diagnostics Infectious Disease Testing Consumption Market Share by Type in 2021
Figure 20. Americas Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application in 2021
Figure 21. United States Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Region in 2021
Figure 26. APAC Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application in 2021
Figure 27. China Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Country in 2021
Figure 34. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type in 2021
Figure 35. Europe Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application in 2021
Figure 36. Germany Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size Market Share by Application in 2021
Figure 44. Egypt Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Molecular Diagnostics Infectious Disease Testing Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 50. APAC Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 51. Europe Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 53. United States Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 54. Canada Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 57. China Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 58. Japan Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 59. Korea Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 61. India Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 62. Australia Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 63. Germany Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 64. France Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 65. UK Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 66. Italy Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 67. Russia Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 68. Spain Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 71. Israel Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Molecular Diagnostics Infectious Disease Testing Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
